Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05046964 · ClinicalTrials.gov registry record
The PPHgb Study: Non-Invasive Hemoglobin Measurement
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 119
- Enrollment target
NCT05046964 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 119 participants.
The verdict
NCT05046964 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
Study Summary
This project is a prospective observational study aimed to assess the use of non-invasive hemoglobin measurement in anticipating postpartum hemorrhage and predicting estimated blood loss. The non-invasive hemoglobin device is the Radical-7 Pulse CO-Oximeter which is a spectrophotometer manufactured by Masimo, Inc. Participants in the study will be undergoing a cesarean delivery at the George Washington University Hospital and during delivery the patient will wear the device on their fingertip so that hemoglobin measurements can be continuously recorded. No changes from routine medical management will occur during the study.
Interventions
- DEVICE Masimo Radical-7 Pulse CO-Oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2023-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05046964
The ClinicalTrials.gov registry entry for NCT05046964 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo Radical-7 Pulse CO-Oximeter is the first listed.
NCT05046964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05046964 about?
NCT05046964 is a clinical study titled "The PPHgb Study: Non-Invasive Hemoglobin Measurement". This project is a prospective observational study aimed to assess the use of non-invasive hemoglobin measurement in anticipating postpartum hemorrhage and predicting estimated blood loss. The non-invasive hemoglobin device is the Radical-7 Pulse CO-Oximeter which is a spectrophotometer manufactured ...
What is the current status of trial NCT05046964?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2020-11-02. Estimated completion is 2023-05-05.
What interventions are being tested in trial NCT05046964?
The interventions under investigation include: Masimo Radical-7 Pulse CO-Oximeter (DEVICE).
Who is sponsoring clinical trial NCT05046964?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.